GoHealth, Inc. (GOCOQ)
OTCMKTS · Delayed Price · Currency is USD
0.3370
+0.0270 (8.71%)
Inactive · Last trade price on Jul 21, 2026
GoHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 152.79 | 361.85 | 798.89 | 734.67 | 631.68 | 1,062 | |
Revenue Growth | -81.69% | -54.71% | 8.74% | 16.30% | -40.54% | 21.09% |
Cost of Revenue | 65.17 | 96.13 | 130.61 | 158.96 | 187.67 | 239.34 |
Gross Profit | 87.62 | 265.72 | 668.28 | 575.71 | 444.01 | 823.08 |
Selling, General & Admin | 201.98 | 313.21 | 539.33 | 507.35 | 584.99 | 782.43 |
Research & Development | 33.53 | 34.9 | 41.05 | 43.3 | 46.09 | 48.43 |
Amortization of Goodwill & Intangibles | 47.03 | 70.54 | 94.06 | 94.06 | 94.06 | 94.06 |
Operating Expenses | 282.53 | 418.66 | 674.43 | 644.7 | 725.14 | 924.91 |
Operating Income | -194.91 | -152.94 | -6.15 | -68.99 | -281.14 | -101.83 |
Interest Expense | -102.15 | -87.32 | -72.87 | -69.47 | -57.07 | -33.51 |
Other Non Operating Income (Expenses) | 0.34 | 0.79 | 0.83 | 0.04 | 0.12 | 0.67 |
EBT Excluding Unusual Items | -296.72 | -239.47 | -78.18 | -138.43 | -338.09 | -134.67 |
Merger & Restructuring Charges | 0.7 | - | -0.9 | -2.7 | -37.53 | - |
Impairment of Goodwill | - | - | - | - | - | -386.55 |
Asset Writedown | -259.95 | -259.96 | - | -9.99 | - | -1.06 |
Other Unusual Items | -1.86 | -1.66 | 74.03 | - | - | -11.94 |
Pretax Income | -557.83 | -501.09 | -5.05 | -151.12 | -375.62 | -534.22 |
Income Tax Expense | -3.73 | -3.34 | 2.27 | 0.15 | 0.76 | -0.02 |
Earnings From Continuing Operations | -554.11 | -497.76 | -7.32 | -151.27 | -376.38 | -534.19 |
Minority Interest in Earnings | 264.22 | 240.63 | 4.39 | 88.01 | 227.68 | 344.84 |
Net Income | -289.89 | -257.13 | -2.93 | -63.26 | -148.71 | -189.36 |
Preferred Dividends & Other Adjustments | 3.99 | 3.92 | 3.66 | 3.57 | 0.94 | - |
Net Income to Common | -293.88 | -261.05 | -6.59 | -66.82 | -149.65 | -189.36 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 14 | 13 | 10 | 9 | 8 | 7 |
Shares Outstanding (Diluted) | 14 | 13 | 10 | 9 | 8 | 7 |
Shares Change | 41.91% | 29.66% | 7.40% | 10.03% | 19.52% | 25.91% |
EPS (Basic) | -20.41 | -20.17 | -0.66 | -7.19 | -17.72 | -26.80 |
EPS (Diluted) | -20.41 | -20.17 | -0.66 | -7.19 | -17.72 | -26.80 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -107.76 | -130.2 | -35.34 | 95.41 | 47.39 | -318.81 |
Free Cash Flow Per Share | -7.49 | -10.06 | -3.54 | 10.27 | 5.61 | -45.12 |
Gross Margin | 57.34% | 73.43% | 83.65% | 78.36% | 70.29% | 77.47% |
Operating Margin | -127.57% | -42.27% | -0.77% | -9.39% | -44.51% | -9.59% |
Profit Margin | -192.35% | -72.14% | -0.83% | -9.10% | -23.69% | -17.82% |
Free Cash Flow Margin | -70.53% | -35.98% | -4.42% | 12.99% | 7.50% | -30.01% |
EBITDA | -147.98 | -79.83 | 91.64 | 28.95 | -180.64 | 1.48 |
EBITDA Margin | -96.85% | -22.06% | 11.47% | 3.94% | -28.60% | 0.14% |
D&A For EBITDA | 46.94 | 73.11 | 97.79 | 97.95 | 100.5 | 103.31 |
EBIT | -194.91 | -152.94 | -6.15 | -68.99 | -281.14 | -101.83 |
EBIT Margin | -127.57% | -42.27% | -0.77% | -9.39% | -44.51% | -9.59% |
Advertising Expenses | - | 104.9 | 201.7 | 188.3 | 178.7 | 323.3 |